Skandinaviska Enskilda Banken (SEB)
PCRX icon

Skandinaviska Enskilda Banken (SEB)’s Pacira BioSciences PCRX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,800
Closed -$897K – 1118
2021
Q1 		$897K Sell
12,800
-13,600
-52% -$971K 0.01% 855
2020
Q4 		$1.58M Hold
26,400
– – 0.01% 713
2020
Q3 		$1.59M Buy
26,400
+15,500
+142% +$901K 0.01% 637
2020
Q2 		$572K Buy
+10,900
New +$456K ﹤0.01% 794
2019
Q3 		– Sell
-51,900
Closed -$2.26M – 932
2019
Q2 		$2.26M Sell
51,900
-23,300
-31% -$989K 0.02% 476
2019
Q1 		$2.86M Buy
75,200
+15,600
+26% +$609K 0.03% 386
2018
Q4 		$2.56M Sell
59,600
-11,300
-16% -$527K 0.02% 404
2018
Q3 		$3.48M Sell
70,900
-4,300
-6% -$186K 0.03% 363
2018
Q2 		$2.41M Sell
75,200
-8,100
-10% -$280K 0.02% 391
2018
Q1 		$2.6M Buy
83,300
+72,500
+671% +$2.58M 0.03% 328
2017
Q4 		$493K Sell
10,800
-64,800
-86% -$2.57M ﹤0.01% 645
2017
Q3 		$2.84M Hold
75,600
– – 0.03% 394
2017
Q2 		$3.61M Sell
75,600
-4,400
-6% -$204K 0.03% 355
2017
Q1 		$3.65M Sell
80,000
-43,400
-35% -$1.88M 0.04% 335
2016
Q4 		$3.99M Sell
123,400
-800
-0.6% -$26.7K 0.05% 263
2016
Q3 		$4.25M Buy
+124,200
New +$4.87M 0.05% 286

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s PCRX Position: Q2 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Pacira BioSciences (PCRX) in Q2 2021, closing a stake of 12,800 shares — an estimated $897K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in PCRX in Q3 2016 and held it in 16 quarters. The position peaked at $4.25M in Q3 2016. 262 funds tracked by Wall St. Rank hold PCRX as of Q2 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Pacira BioSciences position as of Q2 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 12,800 Pacira BioSciences shares in Q2 2021, an estimated $897K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Pacira BioSciences in Q3 2016 and held it in 16 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Pacira BioSciences position peaked at $4.25M in Q3 2016.
  • 262 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2021, filed 10 Aug 2021.